TomoTherapy Inc. (Nasdaq:TOMO) is up 16% after investment bank Piper Jaffray added the Madison, Wis.-based maker of radiation therapy systems to its “Alpha List,” a list of companies whose shares Piper believes will move higher in the coming months. Piper reiterated its “buy” rating and $14 price target on TomoTherapy.

In Wednesday afternoon trading, TOMO is up 16.71%, or $1.17, to $8.17. For detailed price information and recent news stories about TomoTherapy, click TOMO.